Mandate

Vinge advises Trill Impact in connection with the acquisition of ID North AB

Vinge advises Trill Impact in connection with the acquisition of ID North AB (”ID North”).

ID North operates within Identity Access Management and cyber security providing IT consulting services, resale and in-house development of IT products with its base in Stockholm. With an ambition to build a leading group that addresses the increasing need for cybersecurity services, the acquisition of ID North comprises one of two platform investments to the new group called European ID Security.

Vinge’s team consisted of Christina Kokko together with Karl Klackenberg, Desirée Hagenfeldt and Nina Gransäter (M&A), Åsa Gotthardsson and Carl Östlund (Employment), Sofia Bergenstråhle (IP), Alva Hägglund (Corporate Commercial), Karl-Hugo Engdahl (IT and GDPR), Tove Lövgren Frisk (Compliance) and Sara Dahlros Sköld (VDR assistant).

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025